News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,547 Results
Type
Article (8026)
Company Profile (140)
Press Release (476284)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166752)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52881)
Employer Resources (14)
FDA (9764)
Job Trends (8575)
News (238202)
Policy (17908)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (485)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33156)
ALS (104)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (262)
Approvals (10371)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6959)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3629)
Cardiovascular disease (218)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47849)
Collaboration (1239)
Commercialization (3)
Compensation (1449)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (737)
Cystic fibrosis (85)
Data (5625)
Denatured (4)
Depression (103)
Dermatology (60)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73678)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87581)
Executive appointments (697)
FDA (12370)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (912)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9314)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (99)
Immuno-oncology (56)
Indications (156)
Infectious disease (943)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8650)
Medtech (8790)
Mergers & acquisitions (14380)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (221)
Neuropsychiatric disorders (38)
Neuroscience (1819)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41212)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15460)
Phase 2 (21371)
Phase 3 (14393)
Pipeline (7236)
Policy (18)
Postmarket research (1570)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3019)
Recruiting (6)
Regulatory (14794)
Reports (20)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (153)
Series B (122)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Last 7 days (457)
Last 30 days (1577)
Last 365 days (19027)
2026 (12075)
2025 (19256)
2024 (22986)
2023 (26540)
2022 (34589)
2021 (37168)
2020 (33469)
2019 (23256)
2018 (17468)
2017 (18767)
2016 (17921)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20222)
2011 (20440)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17879)
Australia (2097)
California (11905)
Canada (3127)
China (517)
Colorado (481)
Connecticut (407)
Delaware (207)
Europe (24619)
Florida (1780)
Georgia (375)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1193)
Massachusetts (7826)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2610)
New Mexico (12)
New York (2811)
North Carolina (1267)
North Dakota (4)
Northern California (5961)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2244)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4942)
Tennessee (119)
Texas (1925)
United States (38674)
Utah (358)
Vermont (1)
Virginia (152)
Washington D.C. (38)
Washington State (921)
West Virginia (1)
Wisconsin (73)
484,547 Results for "innoviva inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
August 5, 2026
·
11 min read
Press Releases
Innoviva to Participate in Upcoming June 2026 Investor Conferences
June 2, 2026
·
2 min read
Press Releases
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
August 11, 2026
·
18 min read
Press Releases
Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress
May 7, 2026
·
10 min read
Press Releases
Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select International Markets
June 16, 2026
·
8 min read
Press Releases
Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress
February 26, 2026
·
13 min read
Press Releases
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
·
2 min read
Press Releases
Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report
March 10, 2026
·
12 min read
Press Releases
Innoviva to Participate in the 37th Annual Piper Sandler Healthcare Conference
November 26, 2025
·
2 min read
Press Releases
Innoviva Reports Third Quarter 2025 Financial Results; Highlights Recent Company Progress
November 5, 2025
·
13 min read
1 of 48,455
Next
